etrasimod
etrasimod is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Velsipity. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- etrasimod
- Brand Names
- Velsipity
- Application Number
- NDA216956
- Sponsor
- Pfizer Laboratories Div Pfizer Inc
- NDC Codes
- 1
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- ETRASIMOD ARGININE
Indications and Usage
1 INDICATIONS AND USAGE VELSIPITY is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults. VELSIPITY is a sphingosine 1-phosphate receptor modulator indicated for the treatment of moderately to severely active ulcerative colitis in adults. ( 1 )